VEGF is reported to counteract toxic‐soluble Aβo‐induced synaptic dysfunction12 (many studies suggests that Aβo induces synapse loss in AD, rather than the Aβ plaque load76). The gene discussed is VEGFA; the disease is Alzheimer disease.